BGB-8035

Product Specifications

CAS Number

2283349-24-4

Target

BTK|||EGFR

Related Pathways

JAK/STAT signaling|||Angiogenesis|||Tyrosine Kinase/Adaptors

Purity

0.9674

Bioactivity

BGB-8035 is an orally available, selective and potent BTK inhibitor with antitumor activity that inhibits BTK, TEC and EGFR.BGB-8035 is used in the study of tumors and autoimmune diseases.

Smiles

C(N)(=O)C1=C2N([C@@H](CCN2)C3CCN(C(C=C)=O)CC3)N=C1C4=CC(OC)=C(C)C(OC)=C4

Molecular Formula

C24H31N5O4

Molecular Weight

453.53

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

457851-01 25 mg

N-[Methyl[1-[6- (trifluoromethyl) -3-pyridinyl]ethyl]-λ4-sulfanylidene]cyanamide

Ask

View Details

457851-02 100 mg

N-[Methyl[1-[6- (trifluoromethyl) -3-pyridinyl]ethyl]-λ4-sulfanylidene]cyanamide

Ask

View Details

A22189-50 50 mg

GR 125743 50mg

Ask

View Details

41347164 1.0 µg

Rpl31 AAV siRNA Pooled Vector

Ask

View Details

AE22626HU-01 48 Tests

Human Calcipressin-1 (RCAN1) ELISA Kit

Ask

View Details

AE22626HU-02 96 Tests

Human Calcipressin-1 (RCAN1) ELISA Kit

Ask

View Details